Cost-Effective Perinatal HBV Transmission Prevention ID'ed

Lamivudine, hepatitis B immune globulin prevent hepatitis B virus transmission cost-effectively

WEDNESDAY, Aug. 31 (HealthDay News) -- In hepatitis B surface-antigen-positive pregnant women, administration of lamivudine or hepatitis B immune globulin (HBIG) in the third trimester is a cost-effective method for prevention of perinatal transmission of hepatitis B, according to a study published in the September issue of Obstetrics and Gynecology.

Elizabeth Ramsey Unal, M.D., from the Medical University of South Carolina in Charleston, and colleagues estimated and compared the cost-effectiveness of maternal administration of either lamivudine or HBIG treatment in the third trimester, for the prevention of perinatal hepatitis B virus transmission versus no maternal treatment. A decision tree model was created, and was first estimated for each treatment using overall transmission rates, and then by stratifying according to maternal hepatitis B virus DNA viral load.

The investigators estimated that for each 100 hepatitis B surface antigen-positive pregnant women, 9.7 and 9.5 cases of chronic hepatitis B virus infection were prevented for those treated with lamivudine and HBIG, respectively. This resulted in cost savings of $5,184 and $5,887, and a gain of 1.3 and 1.2 life-years per patient treated with lamivudine and HBIG, respectively. Under baseline assumptions, lamivudine and HBIG remain cost-effective unless the reduction in perinatal transmission is less than 18.5 and 9.6 percent, respectively.

"In this decision analysis, administration of lamivudine or HBIG to hepatitis B surface antigen-positive pregnant women for the prevention of perinatal transmission of hepatitis B is cost-saving across a wide range of assumptions," the authors write.

Full Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95

Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95

Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95

More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events